KMID : 0311120160570061412
|
|
Yonsei Medical Journal 2016 Volume.57 No. 6 p.1412 ~ p.1419
|
|
Antibody to Fc¥åRI¥á Suppresses Immunoglobulin E Binding to High-Affinity Receptor I in Allergic Inflammation
|
|
Hong Jung-Yeon
Bae Jong-Hwan Lee Kyung-Eun Kim Mi-Na Kim Min-Hee Kang Hyun-Jung Park Eun-Hye Yoo Kyung-Sook Jeong Se-Kyoo Kim Kyung-Won Kim Kyu-Earn Sohn Myung-Hyun
|
|
Abstract
|
|
|
Purpose: High-affinity receptor I (Fc¥åRI) on mast cells and basophils plays a key role in the immunoglobulin E (IgE)-mediated type I hypersensitivity mediated by allergen cross-linking of the specific IgE-Fc¥åRI complex. Thus, prevention of IgE binding to Fc¥åRI on these cells is an effective therapy for allergic disease. We have developed a strategy to disrupt IgE binding to Fc¥åRI using an antibody targeting Fc¥åRI¥á.
Materials and Methods: Fab fragment antibodies, which lack the Fc domain, with high affinity and specificity for Fc¥åRI¥á and effective inhibitory activity against IgE-Fc¥åRI binding were screened. IgE-induced histamine, ¥â-hexosaminidase and Ca2+ release in basophils were determined by ELISA. A B6.Cg-Fcer1atm1Knt Tg(FCER1A)1Bhk/J mouse model of passive cutaneous anaphylaxis (PCA) was used to examine the inhibitory effect of NPB311 on allergic skin inflammation.
Results: NPB311 exhibited high affinity to human Fc¥åRI¥á (KD=4 nM) and inhibited histamine, ¥â-hexosaminidase and Ca2+ release in a concentration-dependent manner in hFc¥åRI-expressing cells. In hFc¥åRI¥á-expressing mice, dye leakage was higher in the PCA group than in controls, but decreased after NPB311 treatment. NPB311 could form a complex with Fc¥åRI¥á and inhibit the release of inflammation mediators.
Conclusion: Our approach for producing anti-Fc¥åRI¥á Fab fragment antibody NPB311 may enable clinical application to a therapeutic pathway in IgE/Fc¥åRI-mediated diseases.
|
|
KEYWORD
|
|
Immunoglobulin E (IgE), high-affinity IgE receptor I (Fc¥åRI), Fab fragment, antibody affinity, passive cutaneous anaphylaxis
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|